Syndax Pharmaceuticals, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 8.30x
Net debt / equity: 5.15x
Debt / assets: 0.73x
Debt / EBITDA: -2.13x
Net debt / EBITDA: -1.32x

Liquidity & coverage

Current ratio: 5.47x
Quick ratio: 5.06x
Cash ratio: 4.09x
Interest coverage: -2.77x
EBITDA / interest: -2.01x
Working capital: $385.0M

Cash & dividend

FCF / debt: -0.81x
Cash flow / debt: -0.81x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.